Key result
Elderly chronic HF links to decreased gut microbiota diversity, altered metabolites, and elevated inflammatory cytokines.
Why the study?
The mechanism and pathogenesis of myocardial remodeling in chronic heart failure remain unknown.
Are there differences in gut microbiota and serum metabolomics between elderly patients with chronic heart failure and healthy subjects?
Case-Control (n=50)
Are there differences in gut microbiota and serum metabolomics between elderly patients with chronic heart failure and healthy subjects?
Elderly patients with chronic heart failure exhibit decreased gut microbiota diversity and altered serum metabolomic profiles that correlate with systemic inflammation.
Gut microbiota changes correlate with inflammation in elderly HF; hypothesis-generating and requires prospective validation before clinical consideration.
Objective . Chronic heart failure (CHF) refers to a state of persistent heart failure that can be stable, deteriorated, or decompensated. The mechanism and pathogenesis of myocardial remodeling remain unknown. Based on 16S rDNA sequencing and metabolomics technology, this study analyzed the gut microbiota and serum metabolome in elderly patients with CHF to provide new insights into the microbiota and metabolic phenotypes of CHF. Methods . Blood and fecal samples were collected from 25 elderly patients with CHF and 25 healthy subjects. The expression of inflammatory factors in blood was detected by ELISA. 16S rDNA sequencing was used to analyze the changes in microorganisms in the samples. The changes of small molecular metabolites in serum samples were analyzed by LC‐MS/MS. Spearman correlation coefficients were used to analyze the correlation between gut microbiota and serum metabolites. Results . Our results showed that the IL‐6, IL‐8, and TNF‐ α levels were significantly increased, and the IL‐10 level was significantly decreased in the elderly patients with CHF compared with the healthy subjects. The diversity of the gut microbiota was decreased in the elderly patients with CHF. Moreover, Escherichia Shigella was negatively correlated with biocytin and RIBOFLAVIN. Haemophilus was negatively correlated with alpha‐lactose, cellobiose, isomaltose, lactose, melibiose, sucrose, trehalose, and turanose. Klebsiella was positively correlated with bilirubin and ethylsalicylate. Klebsiella was negatively correlated with citramalate, hexanoylcarnitine, inosine, isovalerylcarnitine, methylmalonate, and riboflavin. Conclusion . The gut microbiota is simplified by the disease, and serum small‐molecule metabolites evidently change in elderly patients with CHF. Serum and fecal biomarkers could be used for elderly patients with CHF screening.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2021) conducted a case-control in Chronic Heart Failure (n=50). Chronic heart failure (disease state) vs. Healthy subjects was evaluated on Gut microbiota diversity, serum metabolites, and inflammatory factor levels. Elderly patients with chronic heart failure exhibited decreased gut microbiota diversity, altered serum metabolites, and significantly increased IL-6, IL-8, and TNF-α compared to healthy subjects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: